Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of ...

Duo successfully invalidate two CureVac patents in the UK | High Court deems patents invalid due to lack of inventive step and insufficient technical contribution | CureVac “disappointed” but stressed ...

Roche’s chief trademark officer has more than filing and searches on his to-do list—and external counsel must keep up, he ...

A UK court upholds the patent for Astellas Pharma's life-extending prostate cancer treatment | Judgment dismisses attempts by ...

7 March 2022 Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed ...

Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits ...

German pharma giant claims Granules India’s ANDA infringes five patents I Combination therapy Jentadueto among Boehringer’s ...

Janssen Biotech denied permission to appeal invalidation of ustekinumab patent | Samsung Bioepis convinced UK court to revoke ...

Having been involved in more than 30 cases at the UPC, the Bardehle Pagenberg litigator tells Marisa Woutersen why success at the game-changing court is a team effort.